International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

Immunosuppressive Drugs Committee

ISD BIO Brunet Chair 150x200

Chair

Mercé Brunet
Barcelona, Spain

contactus273x169

Contact Us
Scientific Committees
Immunosuppressive Drugs Committee

 2017 19 ISD Bergan Stein Vice chair 150x200

Vice-Chair

Stein Bergan
Oslo, Norway

Background & Purpose of the Committee

  • To provide evidence-based recommendations for TDM of immunosuppressive agents;
  • To promote the knowledge and understanding of immunosuppressive drug analysis and interpretation of results;
  • To enhance communication between scientists and physicians of all disciplines involved in TDM of immunosuppressive drugs; and
  • To encourage the effective application of TDM in transplant medicine, with the aim of optimizing clinical drug use and maximizing the clinical and economic benefits.

Committee Initiatives for 2016/2017

  • Preparation of a review article on Generic Immunosuppressive Drugs and TDM
    Project coordination: Tomasz Pawinski, Pawel Kunicki
  • Formation of a project group “Standardization of Immunosuppressive Drug Measurement Services” (in partnership with the IFCC).
    Project coordination: Christoph Seeger, Maria Shipkova, Uwe Christians and Loralie Langman
  • Preparation of an updated tacrolimus consensus document with the organization of a consensus meeting
    Project coordination: Dennis Hesselink, Teun van Gelder, Pierre Marquet
  • Preparation of standardized LC-MS methods for TDM of biodrugs
    Project coordination: Pierre Marquet
  • Submission of materials for the educational area of the IATDMCT website
    Project coordination: Mercè Brunet, Dennis Hesselink, Maria Shipkova
  • Committee representation at scientific meetings and congresses
    Project coordination: All
    • Scheduled:
      • 4th EFLM-UEMS congress, Warsaw, Poland, Sep 2016 (Wieland, Marquet, Kunicki, Hesselink)
      • 15th IATDMCT Congress, Kyoto, Japan, 2017

Committee Initiatives Completed in 2014/2015

  • Organization of a Consensus Meeting and writing of a Consensus Document on TDM of Everolimus (September 11-12, 2014, Stuttgart, Germany)
    Project coordination: Maria Shipkova, David Holt
  • Writing of a review article for Therapeutic Drug Monitoring on "The need for and opportunities to perform TDM for Belatacept"
    Project coordination: Dennis Hesselink, Teun van Gelder, Stein Bergan.
  • Coordination of a Special Issue on Biomarkers in Transplantation and organization of the IVth Symposium on Biomarkers of Immunosuppression and Clinical Outcome in Transplantation: New Approaches on TDM of Immunosuppressive Drugs (Barcelona, December 2014).
    Project coordination: Mercè Brunet
  • Submission of materials for the educational area of the IATDMCT website
    Project coordination: Dennis Hesselink, Maria Shipkova, Mercè Brunet
  • Committee representation at scientific meetings and congresses
    Project coordination: All
    • IATDMCT regional meeting, Sibiu, Romania, June 6-7, 2014
    • IATDMCT regional meeting, Prague, Czech Republic, August 28-30, 2014
    • Symposium at the EFLM meeting, UK, Liverpool, October 7-10, 2014
    • 14th IATDMCT Congress, The Netherlands, Rotterdam, October 11-15, 2015

Additional Committee Resources

Members must be logged in to access the resources below: